Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Jun 2026.
- Largest single sale: $5.9M (51,375 shares) of Kymera Therapeutics, Inc. on Jun 30, 2026. Filing
- Last sale before this period: Sep 17, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | Aug 20, 2020 | Jul 2, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 30, 2026, Kymera Therapeutics, Inc.: sold 77,109 shares for $8.9M, under a disclosed plan; 61,378 shares acquired by exercising options. 1 filing: 1
- Jun 2, 2026, Kymera Therapeutics, Inc.: 12,653 shares acquired by exercising options. 1 filing: 1
- May 18, 2026, Kymera Therapeutics, Inc.: 15,000 shares acquired by exercising options. 1 filing: 1
- Mar 4, 2026, Kymera Therapeutics, Inc.: sold 4,895 shares for $418K, to cover taxes. 1 filing: 1
- Mar 2, 2026, Kymera Therapeutics, Inc.: sold 7,576 shares for $674K, to cover taxes; 17,650 shares granted. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.